Cell ther­a­py for di­a­betes: New da­ta, ap­proval, buy­out; GLP-1 race in weight loss reach­es new stage; FDA fi­nal­ly ap­proves Bio­Marin’s gene ther­a­py; and more

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it their read­er pro­file to add End­points Week­ly. New to End­points? Sign up here.

For many of our US read­ers, this may be the start of a long week­end as we look ahead to the hol­i­day on Ju­ly 4. A sched­ul­ing note: On Mon­day, Ju­ly 3, we won’t pub­lish our ear­ly edi­tion, but our ear­ly and lat­er af­ter­noon newslet­ters will still be ar­riv­ing in your in­box­es. Have a good week­end.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER